{
    "Trade/Device Name(s)": [
        "C-Reactive Protein Kit for Use on SPAPlus"
    ],
    "Submitter Information": "The Binding Site Group Ltd",
    "510(k) Number": "K161982",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083444"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DCN"
    ],
    "Summary Letter Date": "March 9, 2017",
    "Summary Letter Received Date": "March 10, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5270"
    ],
    "Regulation Name(s)": [
        "C-Reactive Protein Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "C-Reactive Protein (CRP)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "SPAPLUS analyser"
    ],
    "Method(s)/Technology(ies)": [
        "Quantitative immunoturbidimetry",
        "Turbidimetry"
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Calibrator",
        "Control",
        "Buffer"
    ],
    "Document Summary": "FDA 510(k) summary for The Binding Site C-Reactive Protein Kit for Use on SPAPlus, a quantitative immunoturbidimetric assay to measure CRP in serum.",
    "Indications for Use Summary": "Intended for the quantitative in vitro determination of C-reactive protein (CRP) concentration in serum to aid in the evaluation of tissue injury, infection, and inflammatory disorders, for use on the SPAPLUS analyser.",
    "fda_folder": "Immunology"
}